The latest interview in the DCAT Alliance for Industry Women Committee’s Women Leaders in Pharma: An Interview Series features Maha Mehanna, Associate Director of Portfolio Management at XGen Pharmaceuticals DJB, Inc. Read her interview here.

Dr. Maha Mehanna
Dr. Maha Mehanna is the Associate Director of Portfolio Management at XGen Pharmaceuticals DJB, Inc., a privately held generic pharmaceutical company focused on developing and delivering specialty pharmaceutical products. Maha joined XGen after being the Manager of Business Development & Sourcing at i3 Pharmaceuticals, a start-up that focuses on developing high-technological-barrier solid oral generic-drug products, and its sister company, Pontis Pharmaceuticals, LLC, which co-develops complex injectables. Prior to that, Maha was the Operations Manager at Absorption Systems, a pre-clinical CRO, and its sister company, Clayton Pharmaceuticals, which focuses on expanding the reach of Biopharmaceutics Classification System-based biowaivers.

Maha has a multidisciplinary background in chemistry, microbiology, and engineering. She has lived and worked on three different continents. Maha earned her Ph.D. in process and environmental engineering at the Institut National Polytechnique de Toulouse in France. She did her post-doc at Pennsylvania State University in the US. She holds a certificate in Leading with Finance from the Harvard Business School. Maha is an avid skier and cook. She serves on the Board of Directors at PhilaFLAM and is an active volunteer of the DCAT Science & Scholarship Committee.

The Women Leaders in Pharma: An Interview Series provides employees of DCAT Member Companies with the opportunity to hear from women industry leaders on a variety of timely and relevant topics.

In each interview, the women leaders from various DCAT Member Companies share their insights on career development, leadership, mentoring, networking, and more. The interviews are published at least once per month, and the full listing of interviews can be found here, on social media, and in the Alliance for Industry Women’s LinkedIn group.

About the Alliance for Industry Women Committee
DCAT’s Alliance for Industry Women Committee aims to educate, inspire, and empower women in the pharmaceutical industry. DCAT Member Company employees can join the Alliance for Industry Women LinkedIn group to engage in dialogue and share relevant information and resources with industry colleagues.